000078.SZ
Shenzhen Neptunus Bioengineering Co., Ltd. [000078.SZ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
000078.SZ Stock Summary
In the News
000078.SZ Financial details
Company Rating
-
Market Cap
6.16B
Income
-1.09B
Revenue
37.52B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
9.87K
Optionable
No
Shortable
Yes
Earnings
30 Apr 2024
P/E
-8.16
Forward P/E
-
PEG
0.16
P/S
0.23
P/B
1.86
P/C
-
P/FCF
-6.78
Quick Ratio
0.93
Current Ratio
1.07
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.41
EPS next Y
-
EPS next Q
-
EPS this Y
-487.76%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-0.29%
Revenue Q/Q
-13.1%
EPS Q/Q
-94%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-3%
ROE
-23%
ROC
-0.13%
Gross Margin
10%
Oper. Margin
-2%
Profit Margin
-3%
Payout
-74%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.01-3.51
52W High
-14%
52W Low
+29%
RSI
53
Rel Volume
1.53
Avg Volume
20.26M
Volume
31.02M
Perf Week
1.98%
Perf Month
-5.15%
Perf Quarter
10.73%
Perf Half Y
11.69%
-
-
-
-
Beta
0.413
-
-
Volatility
0.03%, 0.06%
Prev Close
1.18%
Price
2.58
Change
1.18%
Company Profile
- Volume Average 20.26M
- Market Capitalization 6.16B
- Employee 9.87K
- CEO Mr. Feng Zhang
- Headquarters Shenzhen,CN
- IPO Date 1998-12-18
-
Website
https://www.neptunus.com 
Shenzhen Neptunus Bioengineering Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products primarily in China. It offers drugs in the fields of anti-tumor, cardio-cerebrovascular, marine drugs, and other fields. The company was founded in 1989 and is based in Shenzhen, China.
